glp-1 study Current Insights, Advantages and Challenges of Small Molecule Glucagon-like Peptide 1 Receptor Agonists: A Scoping Review New study shows popular GLP-1

Late escalation (weeks 1316, 1.7 mg): approaching the therapeutic window used in the weight-management trials

Am J Gastroenterol 119(6):10281037 Osei SP, Akomaning E, Florut TF, Sodhi M, Lacy BE, Aldhaleei WA, Bhagavathula AS (2024) Gastrointestinal safety assessment of GLP-1 receptor agonists in the US: a real-world adverse events analysis from the FAERS database

While these findings describe the average response, individual responses can vary widely, highlighting the complexity of obesity as a disease

Weekly injection timing offers a predictable rhythm that many patients find easier to remember than daily medications

Test, track, and find your own rhythm